Drs Bussel and Kessler discuss treatment of early immune thrombocytopenia (ITP).
Management of Patients with Immune Thrombocytopenia
ITP experts debate different strategies they use in upfront treatment of ITP.
Physicians share concerns with ITP medications and response to COVID-19 and other vaccinations.
ITP experts discuss use of splenectomy for treatment of ITP in their practices.
Dr Bussel discusses the use of fostamatinib in patients who have progressed on TPO agents.
Drs Bussel, Piatek and Kessler discuss treatment of older patients with ITP.
ITP experts share considerations in the treatment of pregnant patients with ITP.
Experts discuss lack of consensus in diagnosis of ITP and challenges physicians face.
Drs Piatek and Bussel discuss sequencing of therapies in ITP.
ITP experts discuss emerging ITP treatment landscape.
Physicians share key takeaways from the discussion on diagnosis and treatment of immune thrombocytopenia.
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
3
Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC
4
Bispecific-Based Approaches Highlight Key Multiple Myeloma Data Set to Emerge at EHA 2026
5